Cancer Clinical Trial - Study of Tumor Treating Fields in Combination with Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05004025

First in Human Early Feasibility Study of Tumor Treating Fields in Combination with Nivolumab and Ipilimumab in Metastatic Uveal Melanoma. Clinical trial adding Tumor Treating Fields targeting liver metastases to standard treatment with nivolumab and ipilimumab for patients with uveal melanoma.

Device

NovoTTF-100L(O), nivolumab, ipilimumab

Trial Type

Interventional

Condition

Metastatic uveal melanoma with liver metastases

Keywords

Uveal melanoma